MDWD
Income statement / Annual
Last year (2023), MediWound Ltd.'s total revenue was $18.69 M,
a decrease of 29.48% from the previous year.
In 2023, MediWound Ltd.'s net income was -$6.72 M.
See MediWound Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$18.69 M
|
$26.50 M
|
$23.76 M
|
$21.76 M
|
$31.79 M
|
$3.40 M
|
$2.50 M
|
$1.56 M
|
$601,000.00
|
$259,000.00
|
| Cost of Revenue |
$15.11 M |
$13.33 M |
$14.99 M |
$14.22 M |
$11.85 M |
$2.09 M |
$1.58 M |
$2.16 M |
$2.52 M |
$2.79 M |
| Gross Profit |
$3.58 M |
$13.17 M |
$8.77 M |
$7.55 M |
$19.94 M |
$1.31 M |
$918,000.00 |
-$600,000.00 |
-$1.92 M |
-$2.53 M |
| Gross Profit Ratio |
0.19 |
0.5 |
0.37 |
0.35 |
0.63 |
0.39 |
0.37 |
-0.39 |
-3.19 |
-9.75 |
| Research and Development
Expenses |
$7.47 M
|
$10.18 M
|
$10.26 M
|
$7.70 M
|
$4.97 M
|
$4.07 M
|
$5.46 M
|
$7.07 M
|
$6.02 M
|
$5.35 M
|
| General & Administrative
Expenses |
$8.57 M
|
$8.33 M
|
$6.11 M
|
$8.69 M
|
$9.31 M
|
$7.99 M
|
$9.14 M
|
$12.49 M
|
$13.29 M
|
$4.72 M
|
| Selling & Marketing
Expenses |
$2.80 M
|
$2.04 M
|
$3.39 M
|
$3.23 M
|
$4.06 M
|
$4.19 M
|
$5.36 M
|
$8.40 M
|
$9.28 M
|
$8.83 M
|
| Selling, General &
Administrative Expenses |
$11.38 M
|
$10.37 M
|
$9.74 M
|
$8.69 M
|
$9.31 M
|
$7.99 M
|
$9.14 M
|
$12.49 M
|
$13.29 M
|
$13.55 M
|
| Other Expenses |
$24,000.00 |
$958,000.00 |
-$710,000.00 |
-$144,000.00 |
$1.17 M |
-$751,000.00 |
$56,000.00 |
$66,000.00 |
$59,000.00 |
$49,000.00 |
| Operating Expenses |
$18.87 M |
$21.51 M |
$19.99 M |
$16.39 M |
$15.45 M |
$5.27 M |
$14.61 M |
$19.56 M |
$19.31 M |
$18.90 M |
| Cost And Expenses |
$33.98 M |
$34.84 M |
$34.98 M |
$30.60 M |
$27.30 M |
$7.36 M |
$16.18 M |
$21.71 M |
$21.83 M |
$21.69 M |
| Interest Income |
$2.34 M |
$270,000.00 |
$11,000.00 |
$297,000.00 |
$434,000.00 |
$412,000.00 |
$0.00 |
$1.27 M |
$288,000.00 |
$4.67 M |
| Interest Expense |
$427,000.00 |
$8.92 M |
$903,000.00 |
$832,000.00 |
$925,000.00 |
$892,000.00 |
$478,000.00 |
$847,000.00 |
$444,000.00 |
$2.11 M |
| Depreciation &
Amortization |
$1.30 M
|
$1.27 M
|
$1.24 M
|
$1.09 M
|
$1.15 M
|
$577,000.00
|
$567,000.00
|
$589,000.00
|
$503,000.00
|
$492,000.00
|
| EBITDA |
-$4.89 M
|
-$18.09 M
|
-$11.22 M
|
-$7.75 M
|
$3.42 M
|
-$5.09 M
|
-$13.12 M
|
-$18.30 M
|
-$20.72 M
|
-$18.33 M
|
| EBITDA Ratio |
-0.26 |
-0.35 |
-0.42 |
-0.36 |
0.18 |
-0.99 |
-5.26 |
-12.56 |
-34.48 |
-62.82 |
| Operating Income Ratio
|
-0.82
|
-0.31
|
-0.47
|
-0.41
|
0.14
|
-1.16
|
-5.48
|
-12.94
|
-35.32
|
-82.73
|
| Total Other
Income/Expenses Net |
$8.76 M
|
-$11.18 M
|
-$2.30 M
|
-$436,000.00
|
-$2.43 M
|
-$1.71 M
|
-$846,000.00
|
$1.27 M
|
-$444,000.00
|
$2.55 M
|
| Income Before Tax |
-$6.53 M |
-$19.52 M |
-$13.52 M |
-$9.28 M |
$2.07 M |
-$5.67 M |
-$14.53 M |
-$18.89 M |
-$21.67 M |
-$18.88 M |
| Income Before Tax Ratio
|
-0.35
|
-0.74
|
-0.57
|
-0.43
|
0.06
|
-1.67
|
-5.82
|
-12.12
|
-36.06
|
-72.88
|
| Income Tax Expense |
$185,000.00 |
$78,000.00 |
$27,000.00 |
$325,000.00 |
-$1.65 M |
-$9.69 M |
$8.46 M |
-$1.27 M |
$861,000.00 |
-$2.55 M |
| Net Income |
-$6.72 M |
-$19.60 M |
-$13.55 M |
-$9.60 M |
$3.72 M |
-$1.06 M |
-$22.15 M |
-$18.89 M |
-$22.09 M |
-$18.88 M |
| Net Income Ratio |
-0.36 |
-0.74 |
-0.57 |
-0.44 |
0.12 |
-0.31 |
-8.87 |
-12.12 |
-36.75 |
-72.88 |
| EPS |
-0.75 |
-3.93 |
-3.48 |
-2.47 |
0.96 |
-0.27 |
-6.64 |
-6.05 |
-7.13 |
-6.65 |
| EPS Diluted |
-0.75 |
-3.93 |
-3.48 |
-2.47 |
0.96 |
-0.27 |
-6.64 |
-6.05 |
-7.13 |
-6.65 |
| Weighted Average Shares
Out |
$9.01 M
|
$4.99 M
|
$3.89 M
|
$3.89 M
|
$3.88 M
|
$3.87 M
|
$3.33 M
|
$3.12 M
|
$3.10 M
|
$2.84 M
|
| Weighted Average Shares
Out Diluted |
$9.01 M
|
$4.99 M
|
$3.89 M
|
$3.89 M
|
$3.88 M
|
$3.87 M
|
$3.33 M
|
$3.12 M
|
$3.10 M
|
$2.84 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
